References
Ashina M (2020) Migraine. N Engl J Med 383:1866–1876
Edvinsson L (2019) Role of CGRP in migraine. Handb Exp Pharmacol 255:121–130
Urits I, Jones MR, Gress K et al (2019) CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep 23:29
Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730–1732
Hansen JM, Charles A (2019) Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs. J Headache Pain 20:96
Durham PL, Garrett FG (2009) Neurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine. Cephalalgia 29(Suppl 2):1–6
Close LN, Eftekhari S, Wang M, Charles AC, Russo AF (2019) Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia 39:428–434
Acknowledgements
We would like to thank Cecilia Baroncini who edited the English text.
Funding
The authors declare that they have nothing to report.
Author information
Authors and Affiliations
Contributions
EM and UP analysed the data and drafted the manuscript; VF, GG, GP and SC acquired and analysed data, and critically revised the manuscript. SC conceived and designed the study.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies involving human participants performed by any of the authors.
Consent to participate
Written informed consent was collected from the patient for the inclusion of deidentified clinical data in a scientific publication, in accordance with the Declaration of Helsinki.
Consent for publication
All Authors agreed with this final version.
Availability of data and materials
The authors take full responsibility for the data, the analysis, and interpretation of the research, and they have full access to all of the data.
Code availability
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Matteo, E., Pensato, U., Favoni, V. et al. Do anti-CGRP drugs have a role in migraine aura therapy?. J Neurol 268, 2273–2274 (2021). https://doi.org/10.1007/s00415-021-10546-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10546-1